BENEFICIENT - CLASS A (BENF)

US08178Q3092 - Common Stock

0.6036  -0.11 (-14.93%)

After market: 0.63 +0.03 (+4.37%)

Fundamental Rating

2

Taking everything into account, BENF scores 2 out of 10 in our fundamental rating. BENF was compared to 220 industry peers in the Capital Markets industry. BENF has a bad profitability rating. Also its financial health evaluation is rather negative. BENF has a correct valuation and a medium growth rate.



0

1. Profitability

1.1 Basic Checks

BENF had negative earnings in the past year.
BENF had a negative operating cash flow in the past year.
In the past 5 years BENF always reported negative net income.
In the past 5 years BENF always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of BENF (-148.54%) is worse than 99.54% of its industry peers.
Industry RankSector Rank
ROA -148.54%
ROE N/A
ROIC N/A
ROA(3y)-192.54%
ROA(5y)-115.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BENF does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

The number of shares outstanding for BENF has been reduced compared to 1 year ago.
BENF has a worse debt/assets ratio than last year.

2.2 Solvency

BENF has an Altman-Z score of -8.99. This is a bad value and indicates that BENF is not financially healthy and even has some risk of bankruptcy.
BENF's Altman-Z score of -8.99 is on the low side compared to the rest of the industry. BENF is outperformed by 95.39% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.99
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.04 indicates that BENF may have some problems paying its short term obligations.
The Current ratio of BENF (0.04) is worse than 97.24% of its industry peers.
A Quick Ratio of 0.04 indicates that BENF may have some problems paying its short term obligations.
BENF's Quick ratio of 0.04 is on the low side compared to the rest of the industry. BENF is outperformed by 97.24% of its industry peers.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04

5

3. Growth

3.1 Past

BENF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 69.56%, which is quite impressive.
The Revenue has grown by 54.14% in the past year. This is a very strong growth!
EPS 1Y (TTM)69.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.03%
Revenue 1Y (TTM)54.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%120.02%

3.2 Future

The Earnings Per Share is expected to grow by 41.85% on average over the next years. This is a very strong growth
Based on estimates for the next years, BENF will show a very strong growth in Revenue. The Revenue will grow by 41.81% on average per year.
EPS Next Y99.69%
EPS Next 2Y41.85%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year119.67%
Revenue Next 2Y41.81%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

4

4. Valuation

4.1 Price/Earnings Ratio

BENF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
BENF is valuated cheaply with a Price/Forward Earnings ratio of 0.07.
Based on the Price/Forward Earnings ratio, BENF is valued cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.83. BENF is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 0.07

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

BENF's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BENF's earnings are expected to grow with 41.85% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.85%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BENF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BENEFICIENT - CLASS A

NASDAQ:BENF (12/20/2024, 8:00:01 PM)

After market: 0.63 +0.03 (+4.37%)

0.6036

-0.11 (-14.93%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)N/A N/A
Inst Owners30.7%
Inst Owner Change0.56%
Ins Owners13.18%
Ins Owner Change-48.6%
Market Cap3.07M
AnalystsN/A
Price Target5.1 (744.93%)
Short Float %8.56%
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-133.55%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)73.25%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.07
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-177.64
EYN/A
EPS(NY)8.16
Fwd EY1351.89%
FCF(TTM)-10.21
FCFYN/A
OCF(TTM)-9.87
OCFYN/A
SpS-6.81
BVpS-32.54
TBVpS-35.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -148.54%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-192.54%
ROA(5y)-115.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover-0.09
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 65.35%
Cap/Sales -5.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z -8.99
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)101.07%
Cap/Depr(5y)N/A
Cap/Sales(3y)16.52%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.03%
EPS Next Y99.69%
EPS Next 2Y41.85%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)54.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%120.02%
Revenue Next Year119.67%
Revenue Next 2Y41.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y49.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y55.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y55.67%
OCF growth 3YN/A
OCF growth 5YN/A